IMM 1.27% 40.0¢ immutep limited

any info from meeting?, page-3

  1. 3,638 Posts.
    lightbulb Created with Sketch. 306
    thanks for the feedback redfaces...appreciated!

    Just like to clarify a few things if I may.

    Firstly...Cvac IS NOT a drug? Am I right in thinking this?
    "Cvac is a unique immunotherapy which harnesses and intensifies the bodies own cancer fighting cells"

    So...all they are doing is taking white blood cells, extracting the dendritic(antigen presenting cells of the immune system) cells, multiplying the dendritic cells in a lab, activating the cells by pulsing a tumor antigen(mucin-1, a protein found on the surface of cancer cells) into them,
    then injecting these cells back into the patient, allowing the immune systen to actvely target and attack tumors.

    Would drug companies be worried aout this revoloutionary and quite simple method of fighting cancer do you think???
    I think they would be extremely worried!

    Should the FDA have much trouble seeing this as an excellent advancement that could prolong the lives of thousands of women???
    I think they should have no trouble at all...especially now that dendreon has paved the way, and we have some very enlightened intelligent(and connected) people on board to take us to the next level.
    Think aout it...they arent there to have a picnic!!!

    • "A key criterion for approval of new cancer treatments is proof that they prolong the life of the patient – only 8% are successful"
    cancer
    • "The success of Dendreon highlights the MAJOR opportunity that Prima Biomed represents for investors and for cancer vacines"
    It would seem this is what Cvac is "Primed" to do!!!

    Coming up...
    • "Orphan Drug Designation for CVac™ ovarian cancer treatment
    – additional assistance from FDA to expedite and optimize drug development"

    "Licensing or sale of Cvac™ to a pharmaceutical/drug major is the target that will trigger early revenue generation for the Company"
    Sounds very promising...

    • "Prima Biomed has 3 non-core assets that represent
    significant divestment opportunities"
    • "The divestment of each of these assets would contribute
    significantly to the company’s balance sheet"
    • "Negotiations in respect of these assets with a number of
    interested parties are ongoing"

    CONTRIBUTE SIGNIFICANTLY!!!! How much did we need for those trials again???? Maybe we wont need those "death spiral" or any other forms of finance, or another capital raising for that matter!

    Another great day for Prima Biomed and another small step towards releiving a lot of suffering in the world!




 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
40.0¢
Change
0.005(1.27%)
Mkt cap ! $569.8M
Open High Low Value Volume
40.0¢ 40.0¢ 39.0¢ $1.746M 4.422M

Buyers (Bids)

No. Vol. Price($)
1 7395 39.5¢
 

Sellers (Offers)

Price($) Vol. No.
40.5¢ 94636 3
View Market Depth
Last trade - 16.10pm 19/06/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.